Rosenberg Ellen

Chief Legal OfficerAMICUS THERAPEUTICS, INC. (FOLD) · full profile →Form 4 · filed Apr 27, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
2 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 27, 2026Disposed to issuer(D)464K$14.50$6.7M0
Apr 27, 2026Disposed to issuer(D)15K$14.50$218K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 27, 2026Disposed to issuer(D)94K0
Apr 27, 2026Disposed to issuer(D)108K0
Apr 27, 2026Disposed to issuer(D)134K0
Apr 27, 2026Disposed to issuer(D)138K0
Apr 27, 2026Disposed to issuer(D)109K0
Apr 27, 2026Disposed to issuer(D)204K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-182251) within minutes of acceptance. Every field above traces to the original document. Verify it directly: